Orris

Cervicitis treatment

I'll look up the medical library skill first, then retrieve cervicitis treatment information.
Reading File
Now I'll search the library and PubMed in parallel for cervicitis treatment.
Finding Sources
Searching PubMed

cervicitis treatment

Good results from the library. Let me read the key sections from Harrison's, Goldman-Cecil, Washington Manual, and Berek & Novak's in parallel.
Reading File
Reading File
Reading File
Reading File
Let me get the Harrison's treatment section and the remaining Berek & Novak table content.
Reading File
Reading File
I now have comprehensive information from multiple authoritative sources. Here is the full answer:

Cervicitis - Treatment

Overview

Cervicitis is inflammation of the cervix, most commonly mucopurulent cervicitis (MPC), which affects the columnar epithelium of the endocervix. The major pathogens are:
  • Neisseria gonorrhoeae (GC)
  • Chlamydia trachomatis (CT)
  • Mycoplasma genitalium (MG)
  • Herpes simplex virus (HSV)
  • Trichomonas vaginalis (less common)
  • Bacterial vaginosis (BV)-associated organisms
  • No identifiable organism in ~50% of cases (even with NAAT)

General Principles

  1. Test before treating - always perform NAATs for GC and CT; NAAT for M. genitalium where available.
  2. Empirical treatment is recommended in most cases pending results, especially if follow-up is uncertain or the patient is at high STI risk (age <25, new/multiple partners, unprotected sex).
  3. Dual coverage (for both GC and CT) is appropriate when GC prevalence is substantial in the patient population.
  4. Treat sexual partners with a similar regimen.
  5. Assess for BV concurrently - untreated BV leads to persistent cervicitis symptoms.
  6. Fluoroquinolones are no longer recommended for gonococcal cervicitis due to widespread resistance.

Treatment Regimens by Pathogen

1. Gonorrhea (N. gonorrhoeae) Cervicitis

First-line:
  • Ceftriaxone 500 mg IM single dose + doxycycline 100 mg PO twice daily x 7 days (if CT not excluded)
If ceftriaxone unavailable (alternative, not preferred):
  • Cefixime 800 mg PO x 1 + doxycycline 100 mg PO twice daily x 7 days (only if CT not excluded)
Oral cephalosporins are NOT recommended as long as ceftriaxone is available. Fluoroquinolones are contraindicated due to resistance.
(Washington Manual of Medical Therapeutics; Harrison's 22E, p.1147)

2. Chlamydia (C. trachomatis) Cervicitis

First-line:
  • Doxycycline 100 mg PO twice daily x 7 days
Alternative:
  • Azithromycin 1 g PO single dose (less efficacious for rectal co-infection)
  • Levofloxacin 500 mg PO daily x 7 days
  • Ofloxacin 300 mg PO twice daily x 7 days

3. Mycoplasma genitalium Cervicitis

M. genitalium frequently persists after doxycycline alone. A two-step approach is used:
If macrolide resistance testing NOT available:
  • Doxycycline 100 mg PO twice daily x 7 days, followed by moxifloxacin 400 mg PO daily x 7 days
If macrolide resistance testing available:
  • Macrolide-sensitive: Doxycycline x 7 days, then azithromycin 1 g PO x 1 then 500 mg x 3 days
  • Macrolide-resistant: Doxycycline x 7 days, then moxifloxacin 400 mg PO x 7 days
(Washington Manual; Harrison's 22E, p.1148)

4. HSV Cervicitis

Treat with standard antiviral therapy for genital herpes:
  • Acyclovir or valacyclovir (standard genital herpes regimens apply)
  • HSV causes ulcerative lesions on both the ectocervix (squamous) and endocervix (columnar), distinguishing it from GC/CT cervicitis.

5. Empirical Treatment (Pending Results)

When results are pending and risk is high:
  • Ceftriaxone 500 mg IM x 1 (covers GC) + Doxycycline 100 mg PO twice daily x 7 days (covers CT)
  • If M. genitalium is suspected and azithromycin resistance is a concern: consider adding moxifloxacin
  • If BV is co-present: add metronidazole 500 mg PO twice daily x 7 days

Special Considerations

SituationAction
BV co-infectionTreat concurrently (metronidazole); failure to do so leads to persistent symptoms
PregnancyAvoid doxycycline; use azithromycin for CT; ceftriaxone for GC; untreated MPC risks obstetric complications
Disseminated gonococcal infectionCeftriaxone 1 g IM/IV daily x ≥7 days; switch to PO after 24-48h improvement
Risk of PIDEscalate to PID regimen (ceftriaxone + doxycycline x 14 days + metronidazole)
No identified organismBenefit of antibiotics uncertain; consider azithromycin if M. genitalium is suspected

Complications to Watch

  • Progression to pelvic inflammatory disease (PID) in 10-40% of untreated lower tract gonococcal infection
  • Bartholin gland abscess (may need incision and drainage)
  • Obstetric complications in pregnancy
  • Increased susceptibility to HIV acquisition with cervical ectopy

Retesting

  • Retest for GC/CT 3 months after treatment (regardless of whether partners were treated)
  • Confirm partner notification and treatment
(Sources: Harrison's Principles of Internal Medicine 22E, p.1147-1148; Washington Manual of Medical Therapeutics; Berek & Novak's Gynecology, p.815-816; Goldman-Cecil Medicine, p.3093)
This is a shared conversation. Sign in to Orris to start your own chat.